Deal maker Link resigns from Corange

Max Link's resignation as the CEO of Corange Ltd. will not affect the biotech deals he negotiated for Corange - the $206 million Protein Design Labs deal and the $220 million CellPro Inc. deal, according to Patrick Enright, senior vice president of finance and business development of Corange's Boehringer-Mannheim Therapeutics. However, the executive's exodus may influence